After moving down to $1, Ampio Pharmaceuticals, Inc. (OTC:AMPE) started to climb up again. Yesterday, its 
price went up to $1.30 per share, and traded volume jumped up tremendously to exceed 2 thousand shares for the day.
What’s behing the present move? It should be the positive announcements along with the optimistic projections, released by AMPE over the last days. Could be these, that made the investors start buying, though the news is related to the future and the high expectations cannot be confirmed yet.
Ampio Pharmaceuticals develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. According to the historical data, AMPE has traded much higher during the last 6 months, when its price reached $4.05 per share. However, there was a shocking price crash in June, this year. After that the stock has had frequent ups and downs to start moving up again. Still, its too soon an uptrend to be recorded.
The quarterly results of AMPE look disappointing. They point that the company has not generated any revenue so far, and it has suffered higher expenses. AMPE still has some cash on hand, though its operating loss has increased.
In its 2010 quarterly report, Ampio states that its: “Cash equivalents consist primarily of money market investments”, and that the company needs to raise additional capital to complete its business plan.
Based on these facts, traders should carefully observe the future movement of the AMPE stock.
